Clinical Trial Update: Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pevonedistat in combination with azacitidine for patients with myelodysplastic syndromes or myeloproliferative neoplasms who failed pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Pevonedistat (pevonedistat)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Myelodysplastic Syndromes, Myeloproliferative Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2023-11-21